Pacira Biosciences, Inc. (PCRX) — DEFA14A Filings

All DEFA14A filings from Pacira Biosciences, Inc.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (3)

  • Pacira BioSciences Files Proxy Statement — Apr 18, 2025 Risk: low
    Pacira BioSciences, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 18, 2025. This filing is soliciting material under Rule 14a-12, indicating it con
  • Pacira BioSciences Files Proxy Statement — Apr 17, 2025 Risk: low
    Pacira BioSciences, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 17, 2025, related to its annual meeting. The filing indicates that the company is
  • Pacira BioSciences Files Proxy Statement — Mar 14, 2025 Risk: low
    Pacira BioSciences, Inc. filed a Definitive Proxy Statement (DEFA14A) on March 14, 2025, related to soliciting materials under Section 240.14a-12. The filing in

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.